Login / Signup

CHIPing away at proteomics to find correlations with myeloid neoplasms.

Avni M BhalgatJustin Taylor
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Plasma proteomic profiling to identify associations with myeloid neoplasm (MN) risk, highlights the potential of integrating protein and genetic biomarkers for detection individuals at high-risk of developing MN. These proteins also offer valuable insights into biological pathways and inflammatory mechanisms involved in the progression of clonal hematopoiesis (CH) to MN.
Keyphrases